Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

21.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
21.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

5.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.1K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

7.2K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

6.5K
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary fiber selectively regulates intestinal persistence of probiotic bifidobacteria.

bioRxiv : the preprint server for biology·2026
Same author

An S752D activation loop mutation dynamically primes Muscle-Specific Kinase for activation.

The Biochemical journal·2026
Same author

Dynamic Reprogramming of PDGFRA-Expressing Stromal Cells Facilitates WNT-Driven Transformation by Promoting a Fetal-Like State in the Intestinal Epithelium.

Cancer research·2026
Same author

Lipids regulate epidermal growth factor receptor activation by its ligands.

Biochemical Society transactions·2026
Same author

The role of kinase domain dimerization in EGFR activation.

Structure (London, England : 1993)·2025
Same author

Iron at the crossroads of host-microbiome interactions in health and disease.

Nature microbiology·2025

Related Experiment Video

Updated: Apr 20, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.5K

Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor.

Nicholas J Bessman1, Atrish Bagchi2, Kathryn M Ferguson2

  • 1Graduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Biochemistry and Biophysics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

Cell Reports
|December 3, 2014
PubMed
Summary

Epidermal growth factor receptor (EGFR) allosteric regulation is complex. Ligand binding and receptor dimerization compete, challenging previous assumptions about EGFR activation mechanisms in cancer.

More Related Videos

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
09:16

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Published on: September 11, 2015

8.8K
Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis
10:43

Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis

Published on: November 6, 2019

7.5K

Related Experiment Videos

Last Updated: Apr 20, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.5K
Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
09:16

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Published on: September 11, 2015

8.8K
Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis
10:43

Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis

Published on: November 6, 2019

7.5K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Signaling

Background:

  • Epidermal growth factor receptor (EGFR) is crucial for development and implicated in various cancers.
  • The intricate allosteric regulation of EGFR is not fully understood, particularly the loss of negative cooperativity in its extracellular region (ECR).

Purpose of the Study:

  • To investigate the relationship between ligand binding and receptor dimerization in EGFR.
  • To elucidate the mechanisms underlying EGFR allosteric regulation and the impact of oncogenic mutations.

Main Methods:

  • Studied the extracellular region (ECR) of EGFR.
  • Analyzed ligand binding and receptor dimerization dynamics.
  • Investigated the structural consequences of forcing EGFR ECR into preformed dimers.
  • Examined the effect of glioblastoma-associated EGFR mutations on ligand binding and dimerization.

Main Results:

  • Ligand binding and EGFR dimerization were found to compete, with ligand binding promoting dimerization rather than vice versa.
  • Forcing EGFR ECRs into dimers without ligand resulted in unstable, heterogeneous structures.
  • EGFR-activating mutations in glioblastoma increased ligand-binding affinity but did not directly induce dimerization.

Conclusions:

  • EGFR allosteric regulation involves a competitive interplay between ligand binding and dimerization.
  • Oncogenic EGFR mutations may disrupt the allosteric linkage between dimerization and ligand binding, impacting receptor activation.
  • These findings offer new insights into EGFR activation by ligands and pathological mutations.